Raymond James & Associates’s NUVEEN EQUITY PREMIUM ADVANTAGE FUND JLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-18,640
Closed -$243K 2384
2014
Q3
$243K Sell
18,640
-25,600
-58% -$342K ﹤0.01% 2112
2014
Q2
$588K Sell
44,240
-1,200
-3% -$15.8K ﹤0.01% 1769
2014
Q1
$577K Buy
45,440
+3,200
+8% +$40.7K ﹤0.01% 1723
2013
Q4
$534K Buy
42,240
+10,000
+31% +$124K ﹤0.01% 1642
2013
Q3
$391K Buy
32,240
+2,025
+7% +$25.2K ﹤0.01% 1690
2013
Q2
$373K Buy
+30,215
New +$381K ﹤0.01% 1639

Raymond James & Associates's JLA Position: Q4 2014 in Review

Raymond James & Associates sold out of NUVEEN EQUITY PREMIUM ADVANTAGE FUND (JLA) in Q4 2014, closing a stake of 18,640 shares — an estimated $243K sold.

Raymond James & Associates first reported a position in JLA in Q2 2013 and held it in 6 quarters. The position peaked at $588K in Q2 2014. 0 funds tracked by Wall St. Rank hold JLA as of Q4 2014.

  • Raymond James & Associates reported no remaining NUVEEN EQUITY PREMIUM ADVANTAGE FUND position as of Q4 2014 after selling out during the quarter.
  • Raymond James & Associates sold 18,640 NUVEEN EQUITY PREMIUM ADVANTAGE FUND shares in Q4 2014, an estimated $243K.
  • Raymond James & Associates first reported a position in NUVEEN EQUITY PREMIUM ADVANTAGE FUND in Q2 2013 and held it in 6 quarters.
  • Raymond James & Associates's NUVEEN EQUITY PREMIUM ADVANTAGE FUND position peaked at $588K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held NUVEEN EQUITY PREMIUM ADVANTAGE FUND as of Q4 2014.

Based on Raymond James & Associates's 13F filing for Q4 2014, filed 11 Feb 2015.